Avandia overshadows GSK's new diet pill launch

Stockholder suits over GlaxoSmithKline's diabetes drug Avandia are overshadowing the U.S. launch of its new diet drug. Alli is the first over-the-counter diet drug approved by the FDA, and GSK is making a big financial investment in its U.S. debut.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ